stockrowPACS Group, Inc.
PACS Healthcare Medical Care Facilities
PACS Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $5.3 billion, up 29.3% from fiscal 2024.
- Revenue
- +11.5%
- EPS
- +16.4%
- Free cash flow
- −4.31%
- Total debt
- +7.48%
Quarter to September 2026, against a year earlier
Follow PACS
Alert me
PACS Group, Inc. (PACS) Shares outstanding
PACS Group, Inc.'s shares outstanding at the end of fiscal 2025 was $156.7M, up 5.47% from $148.6M in fiscal 2024. At the end of the quarter to 30 September 2026 it was $163.9M. Over the past ten years it has ranged from $128.7M (fiscal 2023) to $156.7M (fiscal 2025) — the current reading is the highest in ten years. PACS Group, Inc. ranks 6th of 48 Medical Care Facilities companies by shares outstanding.
Shares outstanding, annual
Embed this chart
Annual newest first
| Period | Shares outstanding | Change |
|---|---|---|
| FY2025 | $156.7M | 5.47% |
| FY2024 | $148.6M | 15.42% |
| FY2023 | $128.7M | 0.00% |
| FY2022 | $128.7M | 0.00% |
| FY2021 | $128.7M | — |
Quarterly newest first
| Period | Shares outstanding | Change |
|---|---|---|
| Sep 2026 | $163.9M | 1.19% |
| Jun 2026 | $162.0M | (0.06%) |
| Mar 2026 | $162.1M | 3.43% |
| Dec 2025 | $156.7M | (4.86%) |
| 11 more quarters | Free account |
Against its own ten years
Shares outstanding against peers
| Company | Shares outstanding |
|---|---|
| FMS Fresenius Medical Care AG & Co. KGaA compare | $525.9M |
| LFST LifeStance Health Group, Inc. compare | $391.2M |
| PACS PACS Group, Inc. | $163.9M |
| OPCH Option Care Health, Inc. compare | $150.5M |
| CON Concentra Group Holdings Parent, Inc. compare | $127.8M |
| DVA DaVita Inc. compare | $65.5M |
| ENSG The Ensign Group, Inc. compare | $59.3M |
| UHS Universal Health Services, Inc. compare | $59.1M |
| CHE Chemed Corporation compare | $13.1M |
What Shares outstanding is
Shares (Diluted, Weighted) tells an investor how many shares a company’s earnings are spread across once potential new shares are counted.
Reported line item
More on PACS
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Book value per share
- Revenue growth
- Beneish M-score
- The full statement